In-vitro activity of new carbapenem antibiotics: comparative studies with meropenem, L-627 and imipenem against pathogenic Nocardia spp. 1992

K Yazawa, and Y Mikami, and S Ohashi, and M Miyaji, and Y Ichihara, and C Nishimura
Research Center for Pathogenic Fungi and Microbial Toxicoses, Chiba University, Japan.

MICs of two new carbapenems, meropenem and L-627, and imipenem were determined against 98 strains of the Nocardia asteroides group (i.e. N. asteroides sensu stricto, Nocardia farcinica and Nocardia nova), 46 strains of Nocardia brasiliensis and 17 strains of Nocardia otitidiscaviarum. Meropenem and L-627 were less active against the N. asteroides group than imipenem. Among the three species of the N. asteroides group, N. nova was the most sensitive to all the carbapenems. Meropenem was more active than imipenem against both N. brasiliensis and N. otitidiscaviarum with MIC50 values of 28.3-53.3 mg/L. L-627 was less active than meropenem.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009615 Nocardia A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for humans and animals. Micropolyspora
D000077731 Meropenem A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients. 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid,Merrem,Penem,Ronem,SM 7338,SM-7338,SM7338
D013845 Thienamycins Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors. Antibiotics, Thienamycin,Thienamycin Antibiotics
D015378 Imipenem Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor. Imipemide,N-Formimidoylthienamycin,Imipenem Anhydrous,Imipenem, Anhydrous,MK-0787,MK0787,Anhydrous Imipenem,Anhydrous, Imipenem,MK 0787,N Formimidoylthienamycin
D015780 Carbapenems A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain. Antibiotics, Carbapenem,Carbapenem,Carbapenem Antibiotics

Related Publications

K Yazawa, and Y Mikami, and S Ohashi, and M Miyaji, and Y Ichihara, and C Nishimura
January 1993, Diagnostic microbiology and infectious disease,
K Yazawa, and Y Mikami, and S Ohashi, and M Miyaji, and Y Ichihara, and C Nishimura
April 1994, Antimicrobial agents and chemotherapy,
K Yazawa, and Y Mikami, and S Ohashi, and M Miyaji, and Y Ichihara, and C Nishimura
September 1992, Antimicrobial agents and chemotherapy,
K Yazawa, and Y Mikami, and S Ohashi, and M Miyaji, and Y Ichihara, and C Nishimura
January 1994, The Journal of antimicrobial chemotherapy,
K Yazawa, and Y Mikami, and S Ohashi, and M Miyaji, and Y Ichihara, and C Nishimura
June 1991, Journal of chemotherapy (Florence, Italy),
K Yazawa, and Y Mikami, and S Ohashi, and M Miyaji, and Y Ichihara, and C Nishimura
December 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
K Yazawa, and Y Mikami, and S Ohashi, and M Miyaji, and Y Ichihara, and C Nishimura
April 1995, Toxicology letters,
K Yazawa, and Y Mikami, and S Ohashi, and M Miyaji, and Y Ichihara, and C Nishimura
August 1996, The Journal of antimicrobial chemotherapy,
K Yazawa, and Y Mikami, and S Ohashi, and M Miyaji, and Y Ichihara, and C Nishimura
April 1996, Antimicrobial agents and chemotherapy,
K Yazawa, and Y Mikami, and S Ohashi, and M Miyaji, and Y Ichihara, and C Nishimura
April 2014, Mikrobiyoloji bulteni,
Copied contents to your clipboard!